Skip to content

Clinical trials

Phase 1 Macular Edema trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Macular Edema Phase: Phase 1 Country / region: United States Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20021
20034
20041
20051
20062
20082
20092
20122
20141
20151
20161
20192
20203
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21
Terminated2
Unknown status2
Active, not recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Eye Institute (NEI)10
Novartis Pharmaceuticals2
AiViva BioPharma, Inc.1
GlaxoSmithKline1
Glenn Jaffe1
Kamal Kishore, MD1
Massachusetts Eye and Ear Infirmary1
Shanghai Yao Yuan Biotechnology Ltd. (also known as Drug Farm)1
Soll Eye1
TargeGen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Macular Edema27
Retinal Vein Occlusion7
Uveitis6
Diabetic Retinopathy5
Retinal Diseases5
Diabetes Mellitus4
Macular Degeneration4
Inflammation3
Choroidal Neovascularization2
Diabetes Mellitus, Type 12

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.